Recent Headlines
Within Pharmaceuticals
David Joseph Joins XeroThera as President
XeroThera, Inc, a privately held biomaterials and med tech company, developing breakthrough technologies for tissue engineering and the controlled and targeted delivery of drugs and biological molecules, today announced that David S. Joseph has joined the company as President. He is also joining... - January 18, 2023 - XeroThera
Hemanext Partners with the Miami Chapter of the Sickle Cell Disease Association of America to Support Local Sickle Cell Disease Community
Partnership Will Expand to Include Educational and Donation Event with OneBlood. - January 17, 2023 - Hemanext
Newly Available Horse-Side IgG Test Requires No Refrigeration
VMRD, Inc is excited to share the launch of their latest offering for equine veterinarians, a novel horse-side test to measure IgG in foals. - January 17, 2023 - VMRD, Inc.
NooIQ™: Premium "Min-Stim" Nootropic Adaptogen Supplement Stack for Memory and Learning
NooIQ™ is a premium nootropic multi-supplement capsule based on an exhaustive literature review and 7 years of rigorous R&D. Ingredients such as Choline (CDP and Bitartrate) and Magnesium (Citrate and L-threonate) are often associated with improved memory and learning. Others such as L-theanine support concentration and focus while avoiding the excess stimulants found in nervous-energy producing products such as energy shots, as per the manufacturer's minimally-stimulant ("Min-Stim") philosophy. - January 14, 2023 - Integrity Nootropics
Virb Lands New Contract; Expands Its Offerings to Asias with $10B Life Science Company
Virb has grown outside the US, now servicing contracts in India and Japan with new client. - January 11, 2023 - Virb
End the Legacy, Dedicated to Providing Resources to and Advocating for the Genetic ALS and FTD Community, Presenting to FDA January 12
Individuals impacted by hereditary ALS and FTD announce the establishment of a nonprofit organization dedicated to supporting and advocating for their community, Genetic ALS & FTD: End the Legacy. ALS and FTD are neurodegenerative diseases. ALS affects the motor system and leads to rapidly... - January 10, 2023 - Genetic ALS & FTD: End the Legacy
Huntington Study Group Names First Chief Innovation Officer
The Huntington Study Group (HSG), a world leader in clinical research for Huntington’s Disease (HD) for over 30 years, today announced Brett Kinsler has been named to the newly created position of Chief Innovation Officer (CINO). - January 10, 2023 - Huntington Study Group
Creative Diagnostics Introduces New Hemagglutination Inhibition Assay Services
Creative Diagnostics recently introduced Hemagglutination Inhibition Assay services to determine relative concentrations of viruses, bacteria, or antibodies. - January 06, 2023 - Creative Diagnostics
Creative Diagnostics Expands Its Monoclonal Antibodies Offering to Customers
Creative Diagnostics expanded its monoclonal antibodies capabilities and offerings to global customers. - January 06, 2023 - Creative Diagnostics
The MedServ Group Hosts a Health Care Heroes Campaign
Every day people encounter healthcare heroes who go above and beyond the call of duty to make a difference in the lives of patients. Tell a personal story about a health care hero who will be nominated to win. - January 05, 2023 - The MedServ Group
David Roh Joins AeroGo, Inc. as Western Regional Sales Manager
AeroGo, Inc. is pleased to announce that David Roh has joined the firm as Western Regional Sales Manager. David will manage business relationships and dealer development throughout the western half of the United States and Canada. David will focus on flexible manufacturing solutions and provide... - January 03, 2023 - AeroGo, Inc.
MAKO Medical Expands Popular ASPT-Accredited Phlebotomy Program
Mako Medical and Mako Medical Laboratories expands accredited phlebotomy school to develop and train new students. - December 31, 2022 - Mako Medical Laboratories
Nisha Johari, MD & Co-Founder, JDHL Featured as "Most Influential Business-Woman of the Year 2022"
Mrs Nisha Johari, MD & Co-founder of Johari Digital Healthcare Ltd. has been featured as "The Most Influential Business Women of the Year 2022,” by The CEO Magazine. - December 31, 2022 - Johari Digital Healthcare Ltd.
The Alliance, Powered by Mako Medical, Expands Into New Jersey
Mako Medical expands its presence into New Jersey. The Alliance is a national network of laboratories that are coming together to form one lf the largest labs in America. - December 30, 2022 - Mako Medical Laboratories
Mako Medical Donates $25,000 to Help Families for Christmas
Mako Medical and CEO Chad Price team up with Erica Delong at G105 Radio to help families in need for Christmas. - December 30, 2022 - Mako Medical Laboratories
First Overseas Shipment of CanSinoBIO’s Convidecia Air™ Delivered to Morocco
CanSino Biologics Inc. (“CanSinoBIO” or “the Company”) (SSE: 688185, HKEX: 06185) today announced that the first batch of its Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) for Inhalation (trade name: Convidecia Air™) has arrived in Morocco, providing... - December 30, 2022 - CanSinoBIO
Creative Diagnostics Introduces Plaque Reduction Assay Service for Research Applications
Creative Diagnostics recently introduced Plaque Reduction Assay services to detect antibodies from testing serum and viruses within diseased materials to diagnose viral infectious diseases. - December 28, 2022 - Creative Diagnostics
Creative Diagnostics Launches Anti-Bacterial Antibodies to Support Autoimmune Diseases Research
Creative Diagnostics announced the launch of several mouse antibacterial monoclonal antibodies for the development of human and mouse anti-bacterial antibody detection kits. - December 28, 2022 - Creative Diagnostics
The Catholic Children’s Home Receives a Christmas Surprise
ProCare Health Embraces the Gift of Giving - December 23, 2022 - ProCare Health
Novel Melanoma Diagnostic Tool: MicroRNAs-Associated Extracellular Vesicles Endorsed by Creative Biolabs
Creative Biolabs identifies a suite of exosome services to advance basic research based on microRNAs-associated extracellular vesicles as novel diagnostic tools for melanoma. - December 21, 2022 - Creative Biolabs
Paras Biopharmaceuticals Creates Excellence with “Continuous Biomanufacturing”: Achieves Objectives of “High Productivity & Biomanufacturing Innovation”
With 6 years of dedicated work at Paras Biopharmaceuticals and the use of Paras Biopharmaceuticals’ unique technology platform (which comprises of Bioproduction technologies for economical production of biologics), the company is pleased to announce that an excellent scale-up production process is achieved with “Continuous Biomanufacturing.” - December 19, 2022 - Paras Biopharmaceuticals Finland Oy
The Updated iSpring Learn LMS Saves L&D Managers Hours Every Day While Boosting Their KPIs
The innovative features of iSpring Learn enables SMBs to boost training effectiveness by involving supervisors in training management, increasing employee engagement, and providing smarter event management. - December 12, 2022 - iSpring Solutions Inc.
Paras Biopharma Streamlines Offerings as “Biologics CDMO” and Biosimilar Co-Development as “Paras Biologics”
Paras Biopharmaceuticals Finland Oy today revealed that the company has streamlined and enhanced its business activities with the establishment of a division called, Paras Biologics. In addition to its existing biologics CDMO activities and capabilities (this division is now referred to as Paras Biopharma), the creation of Paras Biologics enhances the company’s biologics and biosimilar pipeline for co-development and licensing opportunities. - December 11, 2022 - Paras Biopharmaceuticals Finland Oy
PharmStars Announces Fall 2022 Accelerator Graduates: 11 Digital Health Startups Complete PharmStars’ Pharma-Focused Accelerator Program
PharmStars, the pharma-focused accelerator for digital health startups, announces the graduation of 11 startups from its Fall 2022 program focused on “Innovations in Real-World Evidence.” The graduating startups successfully completed PharmaU, PharmStars’ 10-week education, and mentoring program. PharmaU culminated with a Showcase Event--held in Boston in early November--that brought together the participating startups and PharmStars’ seven innovation-minded pharma members. - December 08, 2022 - PharmStars
Brooke Spicer Joins Sureguard LLC as Director of Operations
The industry disrupting laboratory services company continues expansion to improve the experience of long-term care facilities. - December 08, 2022 - Sureguard LLC
IVL Creates New Supplement for Optimized Nitric Oxide Support and Better Blood Flow
4 ingredients to support the body's production of Nitric Oxide, a vital molecule for maintaining healthy muscles and blood vessels. - December 08, 2022 - IVL.com
CGO Group Support Foreign Investors in Adapting to Polish Tax and Accounting Regulations
CGO Legal has provided, over the years, legal support to more than 1500 Polish companies, mostly with a foreign ownership structure. The team consists of over 50 qualified experts, specializing in legal, taxation, and accounting fields. They support a new category of clients on the Polish legal... - December 06, 2022 - CGO Legal Chajdas Gawlak Owczarek sp. k.
PharmStars Announces “Innovations in Women’s Health and Health Equity” Theme for Spring 2023 Accelerator
PharmStars, the pharma-focused accelerator for digital health startups, is now accepting applications for its Spring 2023 cohort with the theme “Digital Innovations in Women’s Health and Health Equity.” Startups with digital innovations that promote more equitable, inclusive healthcare for underserved population or focused on women’s health (e.g., breast, ovarian, and cervical cancer; gynecological conditions; osteoporosis; menopausal, hormonal, and reproductive conditions) are welcome to apply. - December 05, 2022 - PharmStars
Clinical Research Organization, Huntington Study Group “Firsts” Continue
The Huntington Study Group (HSG), a world leader in conducting clinical trials for Huntington’s Disease (HD) through its Clinical Research Organization (CRO), HSG Clinical Research, Inc. (HSGCR) continues making groundbreaking progress in the HD world. At their Annual Meeting in November, the... - December 05, 2022 - Huntington Study Group
Paras Biopharmaceuticals Finland Oy is Highly Recommended for Biologics CDMO – Development / Scale-up & Production of Biologics by Innovative USA Biopharma Company
Paras Biopharmaceuticals is pleased to announce that the company has been highly recommended for its Biologics CDMO – development / scale-up and production capabilities. The Paras Biopharmaceuticals Team has successfully completed multiple biologics projects in 2022. - November 29, 2022 - Paras Biopharmaceuticals Finland Oy
Huntington Study Group Annual Meeting
The Huntington Study Group (HSG), a world leader in conducting clinical trials for Huntington’s Disease (HD), recently held its 29th Annual Meeting in Tampa, FL. This renowned meeting brings together HD thought leaders, scientific experts, industry partners and sponsors, advocacy groups, and... - November 29, 2022 - Huntington Study Group
Creative Diagnostics Introduces Hemagglutination Assay Service for Scientific Applications
Creative Diagnostics recently introduced Hemagglutination Assay services for influenza vaccine, diagnostic, and surveillance communities to measure virus and antibody titers and monitor influenza subtypes. - November 26, 2022 - Creative Diagnostics
Creative Diagnostics Announces New Polyethylene Glycol Antibodies Detection Kits
Creative Diagnostics announced the launch of a panel of anti-PEG IgG or IgM ELISA kits with different species reactivity to detect anti-PEG IgG or IgM in serum and plasma. - November 26, 2022 - Creative Diagnostics
David Lim Joins the Team at Microvascular Therapeutics as Director of Finance
Microvascular Therapeutics (MVT), a clinical stage biotechnology company based in Tucson, Arizona, announced the appointment of David Lim as Director of Finance at MVT. Mr. Lim brings a broad experience with the business development and strategic financing for diagnostic pharmaceuticals across all... - November 25, 2022 - Microvascular Therapeutics, Inc.
Marty Rosenberg joins the Board of Scientific Advisors at Microvascular Therapeutics.
Microvascular Therapeutics (MVT), a clinical stage biotechnology company based in Tucson, Arizona, announced the appointment of Marty Rosenberg to the MVT Board of Scientific Advisors. Mr. Rosenberg brings a broad experience with the clinical development and global regulatory approval process for... - November 25, 2022 - Microvascular Therapeutics, Inc.
Morgan County Medical Oncology Practices Combine to Provide Comprehensive Cancer Care
Cancer Care Center of Decatur is joining Clearview Cancer Institute. CCI welcomes Dr. Naveen Lobo. - November 23, 2022 - Clearview Cancer Institute
Novugen Pharma Became the First Pharmaceutical Company in Malaysia to Receive USFDA Approval for Its Manufacturing Facility
The Company was audited in September 2022 and USFDA issued an Establishment Inspection Report (EIR) in November 2022. Novugen Pharma is the first USFDA approved pharmaceutical manufacturing in Malaysia and the only in Southeast Asia. - November 22, 2022 - Novugen
Introducing MIRAPeel MD, the Only 6-in-1 Clinical-Grade Skincare Platform of Its Kind
Attention Dermatologists, Plastic Surgeons and Med Spa Owners: Meet MIRAPeel MD, the one stop shop for all skin needs, and the first of its kind. Offering 6 treatments in one, MIRAPeel MD is setting a new treatment standard for skin care specialists, medical spas, dermatology and plastic surgery offices. - November 22, 2022 - eMIRAmed
iSpring Solutions Inc. Updates Its Range of Stand-Alone Tools to Version 11
iSpring Solutions Inc. Updates Its Range of Stand-Alone Tools to Version 11 and launches special offers on iSpring QuizMaker, iSpring Presenter, iSpring Converter Pro, and other powerful eLearning tools. - November 21, 2022 - iSpring Solutions Inc.
Immunodominant Announces Call for Initial Investment Round as Company Prepares for Phase 2 Study of Oral OTC COVID-19 Drug
Immunodominant Inc., a drug discovery and development company engaged in progressing innovative research from academia to commercialization, today announced its intention to begin an initial financing round of up to $30 million. Immunodominant also announced today that it is scheduling a Phase 2 clinical study after a pre-IND meeting with the FDA for LACTOVID, a novel, oral, over-the-counter drug for the prevention and treatment of COVID-19. - November 20, 2022 - Immunodominant
Microvascular Therapeutics Receives Funds from the National Cancer Institute (NCI) for Its Brain Tumor Program
Microvascular Therapeutics (MVT), a clinical stage biotechnology company based in Tucson, AZ, was recently awarded a Phase I Small Business Innovation Research grant from the National Cancer Institute (NCI). Emmanuelle Meuillet, Chief Scientific and Operating Officer at MVT said, “We are... - November 18, 2022 - Microvascular Therapeutics, Inc.
Shoals Medical Oncology Practices Combine
Clearview Cancer Institute (CCI) and the medical oncology division of North Alabama Cancer Center (NACC), formerly Northwest Alabama Cancer Care, are joining together in Florence and Muscle Shoals, Alabama. - November 17, 2022 - Clearview Cancer Institute
Prosel Bioscience Becomes One Cell Foods and Names Dr. Scott Jenkins Its New CEO
One Cell Food, Inc will focus on scaling its proprietary bioreactor design to commercialize developed strains for its first food product by early 2023. As the new CEO, Dr. Scott Jenkins will lead the operation and fundraising efforts. - November 17, 2022 - One Cell Foods, Inc.
Pregmune Joins Digital Twin Consortium
Pregmune is thrilled to announce that has recently joined the Digital Twin Consortium (DTC), a global initiative created with the goal to be The Authority in Digital Twin(TM) as it relates to policy, security, interoperability, and overall development of digital twins. Founded in 2020 by Dr. - November 17, 2022 - Pregmune
Virb Lands Contract with $10B Life Sciences Company
Begins Series A Financing to Accelerate Growth in the Clinical Research Industry. - November 16, 2022 - Virb
Families of World War II Veterans Holds 2022 Fundraising Golf Tournament
Families of World War II Veterans held its annual golf tournament and fundraising event on Monday, October 24, at the award-winning Trinity Forest Golf Club in Dallas, Texas, the former home of the renowned AT&T Byron Nelson tournament. This is the organization’s biggest fundraising event... - November 12, 2022 - Careington
Are You Ready to Get Shroomed?
After a historical win for the war on drugs in Colorado, the state and the nation begins to look at ways to implement Magic Mushroom assisted therapy along with other plant medicine. We look at the facts behind this, and what it means for you. - November 11, 2022 - shroomed
DataJoint Launches New Cloud-Based System for Automating Neuroscience Experiments
DataJoint's New Cloud Solution Improves Lab Efficiency and Accuracy - November 11, 2022 - DataJoint
WebShield Unveils EasyAccess Rewards, EasyAccess Health, and EasyAccess Funding Enabled by a Self-Funding Privacy Network Exchange
WebShield announces the EasyAccess Network offering identity verification, consent, enrollment, and access for Personal Privacy Network services including EasyAccess Health, EasyAccess Rewards and EasyAccess Funding. These are enabled by the Privacy Network Exchange, Quantum Privacy & Proof of Trust, and allow data, digital content, software, infrastructure, contractual rights, online engagement & brands to be safely combined and re-used with unprecedented privacy, personalization & compliance. - November 11, 2022 - WebShield, Inc.
PharmStars Announces Fall 2022 Startup Showcase Event
PharmStars, the pharma-focused accelerator for digital health startups, announces that its Fall 2022 Showcase Event will begin on November 8, 2022. The Showcase is the culmination of a 10-week startup accelerator program. At the Showcase Event, startups will make formal presentations to and meet... - November 08, 2022 - PharmStars